TUNE-401

N/A

Report date: 2026/04/13 20:02:18
First In Class

Base Information

Drug NameTUNE-401
Drug Alias NameTUNE-401
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Gene therapy > mRNA
Mechanisms of Actioncovalently closed circular DNA inhibitorsHBV DNA Polymerase inhibitors
Targetscovalently closed circular DNAHBV DNA Polymerase
Therapy Area/IndicationsHepatitis, ChronicHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandHong Kong
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTune Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTune Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis, ChronicHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A